|
BRPF3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.532030E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.357900E-02 |
| Normal-vs-Stage2 |
1.879990E-03 |
| Normal-vs-Stage3 |
7.920100E-03 |
| Normal-vs-Stage4 |
3.000200E-01 |
| Stage1-vs-Stage2 |
6.912400E-02 |
| Stage1-vs-Stage3 |
3.857800E-01 |
| Stage1-vs-Stage4 |
4.525600E-01 |
| Stage2-vs-Stage3 |
2.386800E-01 |
| Stage2-vs-Stage4 |
4.006100E-02 |
| Stage3-vs-Stage4 |
1.695830E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.248410E-02 |
| Normal-vs-AfricanAmerican |
6.425200E-01 |
| Normal-vs-Asian |
5.916400E-01 |
| Caucasian-vs-AfricanAmerican |
2.019400E-01 |
| Caucasian-vs-Asian |
1.035000E-01 |
| AfricanAmerican-vs-Asian |
9.831800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.676600E-03 |
| Normal-vs-Female |
2.843900E-02 |
| Male-vs-Female |
4.187200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.522200E-02 |
| Normal-vs-Age(41-60Yrs) |
2.657700E-02 |
| Normal-vs-Age(61-80Yrs) |
4.882100E-03 |
| Normal-vs-Age(81-100Yrs) |
8.401700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.328600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.813240E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.284200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.356200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.353600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.391600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.497600E-01 |
| Classical-VS-Follicular |
1.49560000051174E-07 |
| Classical-VS-Other |
3.176200E-01 |
| Classical-VS-Normal |
1.992430E-01 |
| Tall-VS-Follicular |
3.219700E-03 |
| Tall-VS-Other |
3.201400E-01 |
| Tall-VS-Normal |
4.026800E-01 |
| Follicular-VS-Other |
4.943200E-01 |
| Follicular-VS-Normal |
1.56473999999296E-05 |
| Other-VS-Normal |
1.437010E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.783600E-03 |
| Normal-vs-N1 |
1.491240E-01 |
| N0-vs-N1 |
2.919400E-01 |
|
|
